Revenue | ₹625.63Cr |
Net Profits | ₹58.32Cr |
Net Profit Margins | 9.32% |
Marksans Pharma Ltd’s revenue jumped 3.31% since last year same period to ₹625.63Cr in the Q1 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated -13.56% fall in its revenue since last 3-months.
Marksans Pharma Ltd’s net profit fell -34.29% since last year same period to ₹58.32Cr in the Q1 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated -35.59% fall in its net profits since last 3-months.
Marksans Pharma Ltd’s net profit margin fell -36.39% since last year same period to 9.32% in the Q1 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated -25.49% fall in its net profit margins since last 3-months.
The revenue for Marksans Pharma Ltd in the Q1 results 2025 was ₹625.63Cr.
The net profit for Marksans Pharma Ltd in the Q1 results 2025 was ₹58.32Cr.
The net profit margin for Marksans Pharma Ltd in the Q1 results 2025 was 9.32%.
The revenue for Marksans Pharma Ltd in the Q1 results 2024 was ₹605.57Cr.
The net profit for Marksans Pharma Ltd in the Q1 results 2024 was ₹88.75Cr.
The net profit margin for Marksans Pharma Ltd in the Q1 results 2024 was 14.66%.